154 related articles for article (PubMed ID: 4397627)
21. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
[No Abstract] [Full Text] [Related]
22. Double-blind cross-over clinical trial of oxyfedrine in angina pectoris.
Mohindra S; Sharma PL; Wahi PL
J Assoc Physicians India; 1972 Nov; 20(11):829-35. PubMed ID: 4144031
[No Abstract] [Full Text] [Related]
23. [The treatment of angina pectoris with beta receptor blockaders].
Kaltenbach M; Becker HJ; Graef V; Hunscha H
Med Klin; 1971 Mar; 65(11):494-500. PubMed ID: 4996983
[No Abstract] [Full Text] [Related]
24. [Controlled study of the beta-receptor blockader Kö 592 in patients with angina pectoris].
Lerche D
Dtsch Med J; 1971 Jul; 22(14):455-62. PubMed ID: 4398040
[No Abstract] [Full Text] [Related]
25. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
Willems D; Frisch P; Klepzig H
Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
[No Abstract] [Full Text] [Related]
26. Correlation of beta blockade with serum practolol levels after oral administration.
Schneck DW; Aoki VS; Kroetz FW; Wilson WR
Clin Pharmacol Ther; 1972; 13(5):685-93. PubMed ID: 4403358
[No Abstract] [Full Text] [Related]
27. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
Maranhão MF; da Cunha GP; Rojas RI
Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
[No Abstract] [Full Text] [Related]
28. Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests.
Hansen PF; Rasmussen PA; Nyberg G
Acta Med Scand; 1973 May; 193(5):419-24. PubMed ID: 4197873
[No Abstract] [Full Text] [Related]
29. A comparison of intravenous pindolol and propranolol in normal man.
Hicks DC; Arbab AG; Turner P; Hills M
J Clin Pharmacol New Drugs; 1972; 12(5):212-6. PubMed ID: 4402370
[No Abstract] [Full Text] [Related]
30. Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.
Nordenfelt I; Olsson L; Persson S
Eur J Clin Pharmacol; 1974; 7(3):157-62. PubMed ID: 4152812
[No Abstract] [Full Text] [Related]
31. [Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol)].
Erikssen J; Rod T
Tidsskr Nor Laegeforen; 1971 Apr; 91(10):721-5. PubMed ID: 4397025
[No Abstract] [Full Text] [Related]
32. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
Libretti A; Gregorini L; Valentini R
Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
[No Abstract] [Full Text] [Related]
33. [Adrenergic beta-blockade in angina pectoris. A study of the effects of Practolol (Eraldin, I.C.I. 50172) with special attention to the matter of dosage].
Christensen E; Busch M
Ugeskr Laeger; 1971 Feb; 133(7):296-9. PubMed ID: 4396025
[No Abstract] [Full Text] [Related]
34. -Receptor antagonists in angina pectoris.
Prichard BN
Ann Clin Res; 1971 Dec; 3(6):344-52. PubMed ID: 4400460
[No Abstract] [Full Text] [Related]
35. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
Sandler G; Clayton GA
Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
[TBL] [Abstract][Full Text] [Related]
36. The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris.
Aellig WH; Prichard BN; Richardson GA
Br J Pharmacol; 1969 Oct; 37(2):527P-528P. PubMed ID: 4390674
[No Abstract] [Full Text] [Related]
37. Long-term clinical results of oxprenolol in the treatment of cardiac arrhythmias, angina pectoris and hypertrophic subaortic stenosis.
Scebat L; Bensaid J
Postgrad Med J; 1970 Nov; ():Suppl:86-90. PubMed ID: 4395465
[No Abstract] [Full Text] [Related]
38. Trial of two beta blockade drugs, Ciba 39089 and ICI 50172, in angina pectoris.
Nellen M
S Afr Med J; 1969 Dec; ():Suppl:15-7. PubMed ID: 4392020
[No Abstract] [Full Text] [Related]
39. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
Heterington DJ; Comerford MB; Nyberg G; Besterman EM
Br Heart J; 1973 Mar; 35(3):320-33. PubMed ID: 4632566
[No Abstract] [Full Text] [Related]
40. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
Bjerle P; Jacobsson KA
Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
